Blockchain Technology allows multiple industries to improve the way they do business, by offering a transparent, fast, and immutable ledger to store information on. Healthcare is one of those industries that is being revolutionized by this groundbreaking technology. This year, we’re hosting a Healthcare panel with amazing guests with a collective 100+ years in the field of medicine, science, data, engineering, and research. This panel ranges from Charles River, a R&D firm providing comprehensive analysis on drug development products. With 100 sites around the globe, they are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving your product’s unique challenges. CR focuses on timeliness and accuracy in every stage of development means you can count on reliable, reproducible results – every step of the way. (Rep - Thomas Huff) Acoer, a blockchain-powered health software, providing real-time insights and analytics into key healthcare metrics, helping you make informed decisions that prioritize your organization's needs. (Rep - @jnasr Jim Nasr) MyTERA, an occupational health application used to characterize task exposure risk assessments and to provide both companies and individual workers the ability to record their occupational exposures utilizing Hedera technology. (Rep - Jeff Miller) HealthReady, a team of clinical trials professionals, technology developers, and researchers who believe in the power of technology and innovation to transform how therapeutics are developed for us, the patients. They are not talking about patient-centric trials, instead, they are enabling patient-driven trials; trials designed and conducted based on what is known about the patient’s genetic and therapeutic profile and not aggregated assumptions. This is more than clinical trial matching; HealthReady is spearheading precision clinical trials with the patients’ permission, responsible patient data governance, and the power of ingenuity. (Rep - Maria Palombini, MBA) UAB Pathology, University of Alabama Birmingham Pathology Department. Their faculty take pride in training the next generation of researchers and clinicians, and we are investing in cutting-edge training programs for graduate students, residents, and fellows to prepare them for success as thought leaders in pathology. UAB’s Pathology department earns approximately $15 million per year in extramural research funding, and last year were ranked #21 for National Institutes of Health grant funding out of all pathology departments in the U.S. They're comprised of seven divisions: Anatomic Pathology, Laboratory Medicine, Molecular & Cellular Pathology, Genomic Diagnostics and Bioinformatics, Neuropathology, Forensics, and Women’s Health. (Rep - Dr. Brandi McCleskey) You DON’T want to miss this panel. Be sure to grab your tickets. Build. Inform. Advance. #Web3ATL